Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development!

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

The recent release of the latest BioRegion Report brought with it some very welcome news for Catalonia, as the autonomous northeastern region of Spain consolidated its place as one of the country’s ...

Swiss pharma giant Novartis came out on top last month in the mergers and acquisitions (M&As) space with its buyout of Massachusetts-based Anthos Therapeutics. The deal is worth up to $2.15 billion in ...

First, let’s take a look at the private biotech investments in February 2025, breaking them down by value, location, funding type, and therapeutic subsector. In February 2025, Eikon Therapeutics ...